Harvard Bioscience (HBIO) Deferred Taxes (2010 - 2019)
Harvard Bioscience (HBIO) reported Deferred Taxes of $42000.0 for Q3 2019, down 74.07% year-over-year from $162000.0 in Q3 2018, and up 4300.0% on a QoQ basis from -$1000.0 in Q1 2019.
Harvard Bioscience (HBIO) has 10 years of Deferred Taxes data on file, last reported at $42000.0 in Q3 2019.
- Quarterly Deferred Taxes fell 74.07% year-over-year to $42000.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was -$2.9 million (down 90.12% YoY) and the FY2018 annual result came in at -$2.9 million, down 80.62% from the prior year.
- Deferred Taxes rose to $42000.0 in Q3 2019 per HBIO's latest filing, from -$1000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $16.1 million in Q4 2015 and bottomed at -$2.9 million in Q4 2018.
- The 5-year median for Deferred Taxes is $1000.0 (2015), against an average of $745214.3.
- The widest annual swing landed in 2015, when Deferred Taxes plunged 1019.05%; it then surged 14933.33% in 2016.
- Tracing HBIO's Deferred Taxes over 5 years: stood at $16.1 million in 2015, then plunged by 104.55% to -$734000.0 in 2016, then slumped by 115.8% to -$1.6 million in 2017, then slumped by 84.79% to -$2.9 million in 2018, then soared by 101.43% to $42000.0 in 2019.
- Per Business Quant, the three latest HBIO Deferred Taxes figures stand at $42000.0 (Q3 2019), -$1000.0 (Q1 2019), and -$2.9 million (Q4 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -339.30 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -73.00 Mn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | - |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | - |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | -41.00 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 43.60 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 40.64 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 29.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | -4.57 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 42,000.00 |
| Mar 31, 2019 | -1,000.00 |
| Dec 31, 2018 | -2.93 Mn |
| Sep 30, 2018 | 162,000.00 |
| Jun 30, 2018 | 1.26 Mn |
| Mar 31, 2018 | -1.35 Mn |
| Dec 31, 2017 | -1.58 Mn |
| Dec 31, 2016 | -734,000.00 |
| Sep 30, 2016 | 451,000.00 |
| Mar 31, 2016 | 4,000.00 |
| Dec 31, 2015 | 16.14 Mn |
| Sep 30, 2015 | 3,000.00 |
| Jun 30, 2015 | -772,000.00 |
| Mar 31, 2015 | -255,000.00 |
| Dec 31, 2014 | 1.15 Mn |
| Sep 30, 2014 | 140,000.00 |
| Jun 30, 2014 | 84,000.00 |
| Mar 31, 2014 | 35,000.00 |
| Dec 31, 2013 | -729,000.00 |
| Sep 30, 2013 | -411,000.00 |
| Jun 30, 2013 | -870,000.00 |
| Mar 31, 2013 | -431,000.00 |
| Dec 31, 2012 | -103,000.00 |
| Sep 30, 2012 | -307,000.00 |
| Jun 30, 2012 | -217,000.00 |
| Mar 31, 2012 | -104,000.00 |
| Dec 31, 2011 | -555,000.00 |
| Sep 30, 2011 | -527,000.00 |
| Jun 30, 2011 | 162,000.00 |
| Mar 31, 2011 | 71,000.00 |
| Dec 31, 2010 | -701,000.00 |
| Sep 30, 2010 | -11.27 Mn |